Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nu Image Medical vs Strut Health

Nu Image Medical
Site position #185

Lower grade

vs+12.1
Strut Health
Site position #28

Higher grade

The verdict

Strut Health takes it — 79.4/100 to 67.3/100.

Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueStrut Health +17
73
90
Dose & formulationStrut Health +20
75
95
Clinical oversightNu Image Medical +15
70
55
Labs & monitoringStrut Health +8
52
60
FulfillmentStrut Health +23
65
88
Contract termsStrut Health +37
55
92
Nu Image Medical · left barStrut Health · right bar

The numbers

MetricNu Image MedicalStrut Health
WeighScore67.3/10079.4/100
GradeCC+
Site position#185#28
SemaglutideFrom $99/mo injection on 12-month supply; RDT from $269/moFrom $99/mo sublingual, $149/mo injectable
TirzepatideFrom $289/mo injection; RDT from $314/moFrom $199/mo either route
CoverageCoverage not published49 states (not Arkansas)
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Nu Image Medical

Site position #185 · C

Strengths

  • Separate public product pages identify both medications and oral formats
  • Publishes injection and tablet starting rates

Where it loses points

  • Lowest semaglutide injection rate requires a twelve-month supply
  • Final charge, renewal and dose-specific terms need confirmation
  • Compounded tablets are not FDA-approved brand-name pills
Strut Health

Site position #28 · C+

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Strengths

  • Sublingual lozenges for both molecules at the same price as the injection — semaglutide from $99/mo, tirzepatide from $199/mo
  • Every route and auto-refill saving published on the product page rather than inside an intake
  • Free physician visit, free shipping and free follow-up care included
  • Cancel, pause or delay yourself with 48 hours' notice

Where it loses points

  • Asynchronous by design — some states need no phone consultation, so you may never speak to the prescriber
  • No published lab or monitoring program
  • Compounded only, with no brand-name lane
  • Not available in Arkansas

Featured provider

Strut Health

Strut Health scores 79.4/100 (C+). The same molecule as a lozenge or an injection at the same price — the one place here where the needle is genuinely optional.

Commercial relationships affect this placement. The score comparison above is separate.

FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard